Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

NCT01165684

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Scottsdale, Arizona, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
View all 67 locations
View Trial Details
Completed

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

NCT00825643

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Mainz, Germany
  • Novo Nordisk Investigational Site Kfar Saba, Israel
View Trial Details
Completed

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

NCT00399711

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
  • Novo Nordisk Investigational Site Glendale, Arizona, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Jonesboro, Arkansas, United States
View all 103 locations
View Trial Details
Completed

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

NCT00819741

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Fuzhou, Fujian, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
View all 17 locations
View Trial Details
Completed

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

NCT00663260

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Vista Medical Research, Inc. Mesa, Arizona, United States
  • Valley Research Fresno, California, United States
  • Marin Endocrine Care & Research, Inc. Greenbrae, California, United States
  • Office Of Richard Cherlin, Md Los Gatos, California, United States
View all 96 locations
View Trial Details
Completed

A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

NCT01880736

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Fukui-shi, Fukui, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
View all 40 locations
View Trial Details

Related conditions